Primicia Para el Cuarto Lanzamiento Espacial de Cedars-Sinai

Cedars-Sinai planea su primer intento de producir células madre en el espacio y su cuarto lanzamiento de experimentos con células madre a la Estación Espacial Internacional. El lanzamiento, financiado por la NASA, está previsto para el 3 de agosto a las 11 a.m. EDT/8 a.m. PDT.

A First for Cedars-Sinai’s Fourth Space Launch

Cedars-Sinai is planning its first-ever attempt to produce stem cells in space and its fourth launch of stem cell experiments to the International Space Station. The NASA-funded launch is scheduled for Aug. 3 at 11 a.m. EDT/8 a.m. PDT.

Q&A: New Frontiers in ALS Research

Clive Svendsen, PhD, executive director of the Board of Governors Regenerative Medicine Institute and professor of Medicine and Biomedical Sciences at Cedars-Sinai, is developing new treatments and models for amyotrophic lateral sclerosis (ALS) using stem cells.

3rd Space Launch of Cedars-Sinai Stem Cells Slated for Jan. 29

Cedars-Sinai and Space Tango are planning their third launch of pilot-scale systems for the automated in-space production of stem cells to the International Space Station.

Mission Ax-2 Set to Launch Stem Cells to Space

Cedars-Sinai investigators, in collaboration with Axiom Space of Houston, are sending stem cells to space in early May to explore whether microgravity can make it easier and more efficient to produce large batches of stem cells.